login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
RIGEL PHARMACEUTICALS INC (RIGL) Stock News
USA
-
Nasdaq
- NASDAQ:RIGL -
US7665597024
-
Common Stock
47.38
USD
+0.17 (+0.36%)
Last: 12/4/2025, 8:00:02 PM
46.3685
USD
-1.01 (-2.13%)
After Hours:
12/4/2025, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
RIGL Latest News, Press Relases and Analysis
All
Press Releases
3 days ago - By: Chartmill
RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL) Meets Minervini Trend Template and High-Growth Momentum Criteria
11 days ago - By: Chartmill
RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL): A GARP Investment with Strong Growth and a Reasonable Price
2 days ago - By: Zacks Investment Research
Should Value Investors Buy Rigel Pharmaceuticals (RIGL) Stock?
8 days ago - By: Zacks Investment Research
- Mentions:
AUPH
Rigel Pharmaceuticals, Inc. (RIGL) Hit a 52 Week High, Can the Run Continue?
9 days ago - By: Rigel Pharmaceuticals, Inc.
Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference
18 days ago - By: Rigel Pharmaceuticals, Inc.
Rigel Announces Publication of Final 5-year Data on REZLIDHIA® (olutasidenib) in Patients with R/R mIDH1 AML in the Journal of Hematology & Oncology
23 days ago - By: Rigel Pharmaceuticals, Inc.
Rigel to Present at the Jefferies Global Healthcare Conference in London
a month ago - By: Zacks Investment Research
Surging Earnings Estimates Signal Upside for Rigel (RIGL) Stock
a month ago - By: Zacks Investment Research
All You Need to Know About Rigel (RIGL) Rating Upgrade to Strong Buy
a month ago - By: Zacks Investment Research
- Mentions:
CATX
Rigel Pharmaceuticals (RIGL) Tops Q3 Earnings and Revenue Estimates
a month ago - By: Rigel Pharmaceuticals, Inc.
Rigel Reports Third Quarter 2025 Financial Results and Provides Business Update
a month ago - By: Benzinga
- Mentions:
KURA
SEE
HRMY
FOLD
...
Earnings Scheduled For November 4, 2025
a month ago - By: Benzinga
A Look Ahead: Rigel Pharmaceuticals's Earnings Forecast
a month ago - By: Rigel Pharmaceuticals, Inc.
Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition
a month ago - By: Zacks Investment Research
- Mentions:
VRTX
ANIP
EXAS
Rigel Gears Up to Report Q3 Earnings: Here's What to Expect
a month ago - By: Rigel Pharmaceuticals, Inc.
Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update
2 months ago - By: Rigel Pharmaceuticals, Inc.
Rigel Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDS
2 months ago - By: Rigel Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
3 months ago - By: Zacks Investment Research
What Makes Rigel Pharmaceuticals (RIGL) a Strong Momentum Stock: Buy Now?
Please enable JavaScript to continue using this application.